# Extensive Staging in Lung Cancer

> **NCT02030444** · NA · TERMINATED · sponsor: **St. Olavs Hospital** · enrollment: 32 (actual)

## Conditions studied

- Lung Neoplasms

## Interventions

- **PROCEDURE:** PET-MRI and EBUS-TBNA

## Key facts

- **NCT ID:** NCT02030444
- **Lead sponsor:** St. Olavs Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08
- **Primary completion:** 2018-08
- **Final completion:** 2018-08
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** due to difficulties with recruiting
- **Last updated:** 2018-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02030444

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02030444, "Extensive Staging in Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02030444. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*